Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in Non-VA and VA Populations

Background: Chronic hepatitis C viral (HCV) infection affects millions of Americans. Health care systems face complex choices between highly efficacious, costly treatments. This study assessed the cost-effectiveness of treatments for chronic, genotype 1 HCV monoinfected, treatment-naïve individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shan, Barnett, Paul G., Holodniy, Mark, Lo, Jeanie, Joyce, Vilija R., Gidwani, Risha, Asch, Steven M., Owens, Douglas K., Goldhaber-Fiebert, Jeremy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942888/
https://www.ncbi.nlm.nih.gov/pubmed/29756049
http://dx.doi.org/10.1177/2381468316671946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942888/
https://www.ncbi.nlm.nih.gov/pubmed/29756049
http://dx.doi.org/10.1177/2381468316671946

Ejemplares similares